Tumour necrosis factor gene polymorphisms and childhood wheezing

European Respiratory Journal

Volumn 26, Issue 4, 2005, Pages 637-646

  Bilolikar, H ^a,b   Nam, A R ^c   Rosenthal, M ^a   Davies, J C ^a   Henderson, D C ^b   Balfour Lynn, I M ^a,b,d  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

^d ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Asthma; Genetics; Paediatric; Tumour necrosis factor

Indexed keywords

LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE DISEASE; ADOLESCENT; ARTICLE; ASTHMA; CAUCASIAN; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; DNA POLYMORPHISM; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED KINGDOM; WHEEZING;

ADOLESCENT; AGE FACTORS; ASTHMA; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; NASAL LAVAGE FLUID; POLYMORPHISM, GENETIC; RESPIRATORY SOUNDS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 26844546286     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.05.00071104     Document Type: Article

References (52)

1. Balfour-Lynn IM, Openshaw P. Viral infection. In: Silverman M, ed. Childhood Asthma and Other Wheezing Disorders. 2nd Edn. London, Arnold, 2002; pp. 205-221.
2. Thomas PS. Tumour necrosis factor-α: The role of multifunctional cytokine in asthma. Immunol Cell Biol 2001; 79: 132-140.
3. 4 production in wheezy infants. Clin Exp Allergy 1994; 24: 121-126.
4. Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen A, McDevitt HO. Heritable major histocompatibility complex II-associated differences in production of tumour necrosis factor α: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA 1990; 87: 1233-1237.
5. Kroeger KM, Carville KS, Abraham LJ. The -308 tumour necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 1997; 34: 391-399.
6. Uglialoro AM, Turbay D, Pesavento PA, et al. Identification of three new single nucleotide polymorphisms in the human tumour necrosis factor-alpha gene promoter. Tissue Antigens 1998; 52: 359-367.
7. Allen RD. Polymorphism of the human TNF-α promoter - random variation or functional diversity? Mol Immunol 1999; 36: 1017-1027.
8. Rink L, Kirchner H. Recent progress in the tumour necrosis factor-α field. Int Arch Allergy Immunol 1996; 111: 199-209.
9. Messer G, Spengler U, Jung MC, et al. Polymorphic structure of the tumour necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J Exp Med 1991; 173: 209-219.
10. Pociot F, Briant L, Jongeneel CV, et al. Association of tumour necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol 1993; 23: 224-231.
11. Haukim N, Bidwell JL, Smith AJ, et al. Cytokine gene polymorphism in human disease: on-line databases, Supplement 2. Genes Immun 2002; 3: 313-330.
12. Huang S-L, Su C-H, Chang S-C. Tumour necrosis factor-α gene polymorphism in chronic bronchitis. Am J Resp Crit Care Med 1997; 156: 1436-1469.
13. Hull J. Thomson AH. Contribution of genetic factors other than CFTR to disease severity in cystic fibrosis. Thorax 1998; 58: 1018-1021.
14. Moffatt MO, Cookson WO. Tumour necrosis factor haplotypes and asthma. Hum Mol Genet 1997; 6: 551-554.
15. Moffatt MF, James A, Ryan G, Musk AW, Cookson WO. Extended tumour necrosis factor/HLA-DR haplotypes and asthma in an Australian population sample. Thorax 1999; 54: 757-761.
16. Chagani T, Pare PD, Zhu S, et al. Prevalence of tumour necrosis factor-α and angiotensin converting enzyme polymorphisms in mild/moderate and fatal/near-fatal asthma. Am J Respir Crit Care Med 1999; 160: 278-282.
17. Winchester EC, Millwood IY, Rand L, Penny MA, Kessling AM. Association of the TNF-α-308 (G-->A) polymorphism with self-reported history of childhood asthma. Hum Genet 2000; 107: 591-596.
18. Wang TN, Chen WY, Wang TH, Chen CJ, Huang LY, Ko YC. Gene-gene synergistic effect on atopic asthma: tumour necrosis factor-alpha-308 and lymphotoxin-alpha-NcoI in Taiwan's children. Clin Exp Allergy 2004; 34: 184-188.
19. Witte JS, Palmer LJ, O'Connor RD, Hopkins PJ, Hall JM. Relation between tumour necrosis factor polymorphism TNFalpha-308 and risk of asthma. Eur J Hum Genet 2002; 10: 82-85.
20. Albuquerque RV, Hayden CM, Palmer LJ, et al. Association of polymorphisms within the tumour necrosis factor (TNF) genes and childhood asthma. Clin Exp Allergy 1998; 28: 578-584.
21. Shin HD, Park BL, Kim LH, et al. Association of tumor necrosis factor polymorphisms; with asthma and serum total IgE. Hum Mol Genet 2004; 13: 397-403.
22. Tan EC, Lee BW, Tay AW, Chew FT, Tay AH. Asthma and TNF variants in Chinese and Malays. Allergy 1999; 54: 402-403.
23. Li Kam Wa TC, Mansur AH, Britton J, et al. Association between - 308 tumour necrosis factor promoter polymorphism and bronchial hyperreactivity in asthma. Clin Exp Allergy 1999; 29: 1204-1208.
24. Malerba G, Trabetti E, Patuzzo C, et al. Candidate genes and a genome-wide search in Italian families with atopic asthmatic children. Clin Exp Allergy 1999; 29: Suppl. 4, 27-30.
25. Trabetti E, Patuzzo C, Malerba G, et al. Association of a lymphotoxin α gene polymorphism and atopy in Italian families. J Med Genet 1999; 36: 323-325.
26. Louis R, Leyder E, Malaise M, Bartsch P, Louis E. Lack of association between adult asthma and the tumour necrosis factor α-308 polymorphism gene. Eur Respir J 2000; 16: 604-608.
27. Zhu S, Chan-Yeung M, Becker AB, et al. Polymorphisms of the IL-4, TNF-α, and FcεRIβ genes and the risk of allergic disorders in at-risk infants. Am J Respir Crit Care Med 2000; 161: 1655-1659.
28. Buckova D, Holla LI, Vasku A, Znojil V, Vacha J. Lack of association between atopic asthma and the tumor necrosis factor alpha-308 gene polymorphism in a Czech population. J Investig Allergol Clin Immunol 2002; 12: 192-197.
29. Campbell DA, Li Kam Wa E, Britton J, Holgate ST, Markham AF, Morrison JF. Polymorphism at the tumour necrosis factor locus and asthma. Monogr Allergy 1996; 33: 125-137.
30. Noguchi E, Yokouchi Y, Shibasaki M, et al. Association between TNFA polymorphism and the development of asthma in the Japanese population. Am J Respir Crit Care Med 2002; 166: 43-46.
31. van Hage-Hamsten M, Johansson E, Kronqvist M, Loughry A, Cookson WO, Moffatt MF. Associations of FcεR1-β polymorphisms with immunoglobin E antibody responses to common inhalant allergens in a rural population. Clin Exp Allergy 2002; 32: 838-842.
32. Balfour-Lynn IM, Valman HB, Silverman M, Webster ADB. Nasal IgA response in wheezy infants. Arch Dis Child 1993; 68: 472-476.
33. Perrey C, Turner SJ, Pravica V, Howell WM, Hutchinson IV. ARMS-PCR methodologies to determine TL-10, TNF-α, TNF-β and TGF-β1 gene polymorphisms. Transpl Immunol 1999; 7: 127-128.
34. Heyrovsky A. A new method for the determination of insulin in plasma and urine. Clin Chim Acta 1956; 1: 470-474.
35. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genetics 2001; 68: 978-989.
36. Stephens M, Donnelly P. A comparison of Bayesian methods for haplotype reconstruction. Am J Hum Genetics 2003; 73: 1162-1169.
37. Altman DG. Practical statistics for medical research. London, Chapman Hall, 1991.
38. Chung KF, Godard P, Adelroth E, et al. Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Taskforce on difficult/therapy-resistant asthma. Eur Respir J 1999; 13: 1198-1208.
39. Payne DNR, Balfour-Lynn IM. Difficult asthma in children: a practical approach. J Asthma 2001; 38: 189-203.
40. Warzocha K, Ribeiro P, Bienvenu J, et al. Genetic polymorphisms in the tumour necrosis factor locus influence non-Hodgkin's lymphoma outcome. Blood 1998; 91: 3574-3581.
41. Sandford AJ, Pare PD. The genetics of asthma. The important questions. Am J Respir Crit Care Med 2000; 161: S202-S206.
42. Hall I. Candidate gene studies in respiratory disease: avoiding the pitfalls. Thorax 2002; 57: 377-378.
43. Ioannidis JPA, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nat Genet 2001; 29: 306-309.
44. Bayley JP, Ottenhoff TH, Verweij CL. Is there a future for TNF promoter polymorphisms? Genes Immun 2004; 5: 315-329.
45. Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LB, Duff GW. An allelic polymorphism within the human tumour necrosis factor α promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 1993; 177: 557-560.
46. Bouma G, Crusius JB, Oudkerk Pool M, et al. Secretion of tumour necrosis factor α and lymphotoxin α in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand J Immunol 1996; 43: 456-463.
47. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumour necrosis factor α promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94: 3195-3199.
48. Di Somma C, Charron D, Deichmann K, Buono C, Ruffilli A. Atopic asthma and TNF-308 alleles: linkage disequilibrium and association analyses. Hum Immunol 2003; 64: 359-365.
49. Stüber F, Petersen M, Bokelmann F, Schade U. A genomic polymorphism within the tumour necrosis factor locus influences plasma tumour necrosis factor-α concentrations and outcome of patients with severe sepsis. Crit Care Med 1996; 24: 381-384.
50. Pedersen S. Early use of inhaled steroids in children with asthma. Clin Exp Allergy 1997; 27: 995-999.
51. Warner JO. The down-side of early intervention with inhaled corticosteroids. Clin Exp Allergy 1997; 27: 999-1001.
52. Martinez FD. What have we learned from the Tucson Children's Respiratory Study? Paediatr Respir Rev 2002; 3: 193-197.